A recent update of 3 consecutive prospective trials with high-dose therapy and autograft, without or with rituximab, as primary treatment for advanced-stage follicular lymphoma shows a sizeable group of patients surviving in continuous complete remission

Tarella C;Ladetto M;Benedetti F;Vitolo U;Pulsoni A;Patti C;Callea V;Rambaldi A;Piccin A;Devizzi L;Musso M;Iannitto E;Spedini P;Liberati AM;CICERI , FABIO;Gallamini A;Rodeghiero F;Gini G;De Crescenzo A;Di Raimondo F;Levis A;Chisesi T;Petrone T;Scalabrini DR;Rossi G;Carella AM;Parvis G;Majolino I;Passera R;Ruella M;Pileri A;Gianni AM;Corradini P.

2010-01-01